These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 6673865

  • 1. [Efficacy of alternate-day corticosteroid administration in the treatment of polymyositis].
    Uchino M, Araki S, Yoshida O, Uekawa K, Nagata J.
    Rinsho Shinkeigaku; 1983 Oct; 23(10):842-6. PubMed ID: 6673865
    [No Abstract] [Full Text] [Related]

  • 2. High single-dose alternate-day corticosteroid regimens in treatment of polymyositis.
    Uchino M, Araki S, Yoshida O, Uekawa K, Nagata J.
    J Neurol; 1985 Oct; 232(3):175-8. PubMed ID: 4031962
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and adverse effects of using large doses of corticosteroid preparations administered every other day].
    Kolomenskaia EA, Andreeva II, Ibragimova GV, Odintsova TA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983 Oct; 83(4):531-6. PubMed ID: 6305069
    [Abstract] [Full Text] [Related]

  • 4. [Corticosteroid therapy of polymyositis].
    Nemet D, Stambuk D, Brzović Z, Plasaj M.
    Neurologija; 1979 Oct; 27(1-4):221-6. PubMed ID: 262012
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic effect of immunosuppressive drugs in polymyositis].
    Saito E, Kinoshita M, Oshima H, Wada F.
    Nihon Naika Gakkai Zasshi; 1986 Aug; 75(8):1097-101. PubMed ID: 3783006
    [No Abstract] [Full Text] [Related]

  • 6. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM, Kuzin MI, Kolomenskaia EA, Gnezditskaia EV, Zefirova GS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979 Aug; 79(3):286-90. PubMed ID: 220823
    [Abstract] [Full Text] [Related]

  • 7. [Subacute polymyositis and "HSDAD" corticosteroid therapy].
    Dekleva I, Jusić A.
    Neurologija; 1978 Aug; 26(1-4):153-6. PubMed ID: 754013
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
    Chotmongkol V, Wongjitrat C, Sawadpanit K, Sawanyawisuth K.
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):172-4. PubMed ID: 15272765
    [Abstract] [Full Text] [Related]

  • 9. Prognosis and treatment of polymyositis with particular reference to steroid resistant patients.
    Yoshioka M, Okuno T, Mikawa H.
    Arch Dis Child; 1985 Mar; 60(3):236-44. PubMed ID: 3985655
    [Abstract] [Full Text] [Related]

  • 10. [Approaches to treatment optimization in idiopathic dermatomyositis].
    Agababov SV, Alekberova ZS, Akhnazarova VD, Kritskova IN, Agababova ML.
    Ter Arkh; 1982 Mar; 54(6):68-71. PubMed ID: 7112425
    [No Abstract] [Full Text] [Related]

  • 11. [Corticosteroid therapy of disseminated sclerosis].
    Lobzin VS, Bardasarova IA, Golovkin VI.
    Sov Med; 1985 Mar; (9):105-9. PubMed ID: 3906928
    [No Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome.
    Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD.
    Arthritis Rheum; 2003 Apr 15; 49(2):172-8. PubMed ID: 12687507
    [Abstract] [Full Text] [Related]

  • 13. [The efficacy of cyclosporin in the treatment of myositis].
    Sánchez Román J, Castillo Palma MJ, Ocaña Medina C, Wichmann I, Chinchón Lara I, Segura Ayestarán DI.
    Rev Clin Esp; 1995 Jul 15; 195(7):449-54. PubMed ID: 7667518
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.
    J Rheumatol; 1999 Jul 15; 26(7):1527-33. PubMed ID: 10405940
    [Abstract] [Full Text] [Related]

  • 15. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC, Ying KY, Mak A, To CH, Szeto ML.
    Rheumatology (Oxford); 2006 Apr 15; 45(4):425-9. PubMed ID: 16234272
    [Abstract] [Full Text] [Related]

  • 16. [Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis].
    Honma M, Ichikawa Y, Akizuki M, Kashiwazaki S, Kondo H, Hashimoto H, Sugawara M, Hanaoka K.
    Ryumachi; 1994 Jun 15; 34(3):616-27. PubMed ID: 8052927
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of glucocorticoids in the combined treatment of destructive pulmonary tuberculosis].
    Iareshko AG.
    Probl Tuberk; 1983 Feb 15; (2):44-7. PubMed ID: 6844331
    [No Abstract] [Full Text] [Related]

  • 18. Polymyositis.
    Raghunathan VS, Rao KS, Srinivasamurty S.
    J Indian Med Assoc; 1969 Apr 01; 52(7):336-8. PubMed ID: 5801866
    [No Abstract] [Full Text] [Related]

  • 19. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH, Withington SG, Anderson AM, Croft RP, Nicholls PG, Van Brakel WH, Smith WC.
    Lepr Rev; 2003 Dec 01; 74(4):311-8. PubMed ID: 14750576
    [Abstract] [Full Text] [Related]

  • 20. Effect of alternate-day prednisolone administration on hypophyseal-adrenocortical activity in dogs.
    Brockus CW, Dillon AR, Kemppainen RJ.
    Am J Vet Res; 1999 Jun 01; 60(6):698-702. PubMed ID: 10376895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.